Quoin Pharmaceuticals, Ltd. (QNRX) › Operating Cash FlowQuoin Pharmaceuticals, Ltd. (QNRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$1.30M2020: -$1.34M2021: -$5.72M2022: -$8.48M2023: -$7.86M2024: -$7.86M2025: -$13.54M-$13.54M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$13.54M-72.3%2024-$7.86M+0.1%2023-$7.86M+7.3%2022-$8.48M-48.3%2021-$5.72M-327.3%2020-$1.34M-3.1%2019-$1.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share